Results 161 to 170 of about 1,064 (212)

A Farewell to Arms… Manufacturing: Learning From a Landmine Producer Who Became a Deminer

open access: yesBusiness Ethics, the Environment &Responsibility, EarlyView.
ABSTRACT Certain industries—labeled “dirty,” “sinful,” “stigmatized,” or “controversial”—are under public scrutiny because of the ethical, social, and environmental concerns that they raise. Previous research has typically focused on the industry or organizational level of analysis, examining how companies in controversial industries can enhance their ...
Marco Guerci, Luca Carollo
wiley   +1 more source

Existentialism and My ‘Postwolf’ Dachshund: Authenticity in the Age of Genetic Engineering

open access: yesBioethics, EarlyView.
ABSTRACT Human genetic engineering has the potential to profoundly alter the traits of future generations, raising critical ethical questions about authenticity and identity. Essentialist perspectives reject genetic engineering, claiming it inherently compromises authenticity by deviating from a species‐typical genome.
Donrich Thaldar
wiley   +1 more source

Thoughtful Accompaniment in Life's Final Stages: Philosophical Practice as a Complement to Ethics Consultation

open access: yesBioethics, EarlyView.
ABSTRACT This paper argues that philosophical practice can complement existing medical ethics structures by offering a publicly accessible space for discourse and negotiation of basic concepts that are relevant to ethical decision making. The potential of collaboration becomes particularly evident by the example of assisted dying: it raises a wide ...
Patrick Schuchter   +3 more
wiley   +1 more source

Organ Donation After Medical Aid in Dying: An Ethical Overview

open access: yesBioethics, EarlyView.
ABSTRACT Organ Donation after Medical Aid in Dying (OD‐MAiD) is currently practised in four countries: Belgium, Canada, the Netherlands, and Spain. While OD‐MAiD shares some similarities with MAiD (absent the possibility of organ donation) and with standard organ donation protocols, the combination of OD and MAiD involves unique circumstances that ...
David Rodríguez‐Arias   +5 more
wiley   +1 more source

Liminal Bioethics for Liminal Statuses: A New Method for Analysing Novel Biological Entities

open access: yesBioethics, EarlyView.
ABSTRACT Novel biological entities such as cell lines and organoids do not typically fit into established conceptual categories, such as ‘human’ or ‘nonhuman’, ‘gift’ or ‘property’. This makes developing robust ethical principles or policy solutions difficult.
Michael Wee, Ilina Singh
wiley   +1 more source

Clinical Ethicists and Medical Assistance in Dying (MAiD): Possible Roles and Challenges

open access: yesBioethics, EarlyView.
ABSTRACT Assisted dying (AD) presents a range of challenges for clinical ethicists (CEs) and healthcare institutions seeking to involve them in its provision. Questions regarding the legitimacy, scope, and nature of CE involvement remain underexplored in the literature.
Vanessa Finley‐Roy   +3 more
wiley   +1 more source

Ethical Counseling on Assisted Suicide in German and Swiss Right‐To‐Die Organizations: Challenges and Perspectives

open access: yesBioethics, EarlyView.
ABSTRACT During the last years, more and more countries have introduced a practice of assisted dying in their medical system and regulated it by separate laws or by additions to the existing body of criminal law. In this respect, the two neighboring countries, Germany and Switzerland, are exceptional cases.
Dieter Birnbacher, Peter Schaber
wiley   +1 more source

Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT2A receptor agonists

open access: yesBritish Journal of Pharmacology, EarlyView.
Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because of their association with counterculture movements and a perceived concern about harm through recreational use, and their consequent legal prohibition in the early 1970s.
Trevor Sharp, Aurelija Ippolito
wiley   +1 more source

Home - About - Disclaimer - Privacy